NCT00777985View on ClinicalTrials.gov

Preventive Effects of Bosentan on the Systemic Cardiovascular Consequence of Sleep Apnea

PHASE2CompletedINTERVENTIONAL

Enrollment

19

Participants

Timeline

Start Date

December 31, 2007

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions

Obstructive Sleep ApneaHypertension

Interventions

DRUG

bosentan

62.5 mg b.i.d for 4 weeks

DEVICE

nasal continuous positive airway pressure (CPAP)

Daily application throughout sleep for 4 weeks

Trial Locations (1)

38043

CHU de Grenoble, Grenoble

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

collaborator

Actelion

INDUSTRY

lead

University Hospital, Grenoble

OTHER